Supplementary Figure 2 from Improving Global Access to Genomic Profiling in Rare Pediatric Cancers

Sameer Farouk Sait; Tara J. O’Donohue; Tejus Bale; Anita S. Bowman; Katherine E. Hill; Emily Stockfisch; Alexandra Giantini-Larsen; Tina Alano; Marc K. Rosenblum; Jamal Benhamida; Ira J. Dunkel; Michael F. Berger; Maria E. Arcila; Marc Ladanyi; Michael V. Ortiz; Julia Glade Bender; Alexandra Miller; Debyani Chakravarty; Kelly Cavender; Benjamin Preiser; Hongxin Zhang; Andrew L. Kung; David B. Solit; Matthias A. Karajannis; Neerav Shukla

doi:10.1158/1078-0432.29759992

Key Points

Main finding reveals that enhancing access to genomic profiling can aid in diagnosing rare pediatric cancers.
Key evidence shows that an analytical pipeline for interpreting ctDNA in cerebrospinal fluid is vital for effective treatment.
Approach includes detailed steps to analyze and interpret ctDNA, which is crucial for understanding tumor characteristics.
Significance lies in the potential for tailored treatments through improved access to genomic resources for rare disease diagnosis.

Implication

Overview of the analytical pipeline improves interpretation of ctDNA in cerebrospinal fluid from rare pediatric cancers, highlighting genomic profiling's significance.

Abstract

Supplementary Figure 2. Overview of the analytical pipeline for interpretation of cerebrospinal fluid (CSF) circulating tumor DNA (ctDNA).

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Sait et al. (2025) studied this question.

synapsesocial.com/papers/689a0c72e6551bb0af8d02e6 https://doi.org/10.1158/1078-0432.29759992

View at Publisher

Ask AI

Bookmark

Share

Supplementary Figure 2 from Improving Global Access to Genomic Profiling in Rare Pediatric Cancers

Key Points

Implication

Abstract

Discussion

Cite This Study

Supplementary Figure 2 from Improving Global Access to Genomic Profiling in Rare Pediatric Cancers

Key Points

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading